- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-PHP.eB vector system (AAV-PHP.eB expression and packaging plasmid system, across the blood-brain barrier(BBB) ) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV-PHP.eB Vector system is including: 1) AAV-PHP.eB Rep-Cap plasmid (AAV-PHP.eB-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV-PHP.eB particle in 293T cell line in high titer using GeneMedi's AAV-PHP.eB Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
With the blood-brain barrier(BBB) crossing propertiy, AAV-PHP.B shows potential applications in CNS (neuron) gene therapy, especially in neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), or neurogenetic disease such as Spinal Muscular Atrophy (SMA) and Huntington's disease(HD).
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Go to AAV
vector system
>>
Map Download
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-PK20 | AAV-PHP.eB Vector System (Amp resistance) 1. AAV-PHP.eB Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3024 | ||
| P-PK20 | AAV-PHP.eB Vector System (Amp resistance) 1. AAV-PHP.eB Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Biotech & Pharma & Medical Device & Diagnostics | |||
| P-PK20 | AAV-PHP.eB Vector System (Amp resistance) 1. AAV-PHP.eB Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK20 | AAV-PHP.eB Vector System (Amp resistance) 1. AAV-PHP.eB Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK20-Kan | AAV-PHP.eB Vector System (Kan resistance) 1. AAV-PHP.eB Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC20 | AAV-PHP.eB Rep-Cap
Plasmid (Amp resistance)
Size：5ug |
Academic | 1719 | ||
| P-RC20 | AAV-PHP.eB Rep-Cap
Plasmid (Amp resistance)
Size：5ug | Biotech & Pharma & Medical Device & Diagnostics | |||
| P-RC20 | AAV-PHP.eB Rep-Cap
Plasmid (Amp resistance)
Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC20 | AAV-PHP.eB Rep-Cap
Plasmid (Amp resistance)
Size：≥10mg |
All | |||
| P-RC20-Kan | AAV-PHP.eB Rep-Cap
Plasmid(Kan resistance)
Size：≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L | Signal Transduction and Targeted Therapy | 2023/10/11 |
| The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer | Molecular Cancer | 2020/3/12 |
| Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice | Nature Metabolism | 2022/11/18 |
| Targeting the transcription factor HES1 by L-menthol restores protein phosphatase 6 in keratinocytes in models of psoriasis | Nature Communications | 2022/12/19 |
| Ciliary Type III Adenylyl Cyclase in the VMH Is Crucial for High-Fat Diet-Induced Obesity Mediated by Autophagy | Advanced science | 2021/11/16 |
| The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression | Cancer communications | 2022/7/18 |
| Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects | Acta Pharmaceutica Sinica B | 2022/12/14 |
| Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease | Sci Adv | 2020/6/29 |
| Palmitoylation of PKCδ by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease | Theranostics | 2024/1/1 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
